Epstein-Barr virus (EBV) infects various cell types in a wide spectrum of benign and
malignant diseases. Laboratory tests for EBV have improved and are increasingly used in …

Hemophagocytic lymphohistiocytosis (HLH) comprises a group of life-threatening immune
disorders classified into primary or secondary HLH. The former is caused by mutations in …

X-linked inhibitor of apoptosis protein (XIAP) has been identified as a potent regulator of
innate immune responses, and loss-of-function mutations in XIAP cause the development of …

The clinical features of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-
HLH) vary significantly, from mild to severe, at the time of the treatment decision. There are …

X‐linked lymphoproliferative disease (XLP) is an inherited immunodeficiency characterized
by the clinical triad of increased susceptibility to primary Epstein–Barr virus (EBV) infection …

Objective: To report our experience in children with primary or secondary hemophagocytic
lymphohistiocytosis (HLH) presented with multiple organ dysfunction syndrome (MODS) in …

Background Hemophagocytic Lymphohistiocytosis (HLH) is a rare and life-threatening
condition characterized by a severe impairment of the immune homeostasis. While Familial …

Haemophagocytic lymphohistiocytosis (HLH) is a fatal haematological disorder with diverse
aetiology. This prospective study was undertaken to characterize HLH cases in Vietnamese …

Epstein–Barr virus (EBV) is an ubiquitous human herpesvirus. Primary infection is generally
subclinical but in certain circumstances, such as in patients with either hereditary or …

Abstract Data on Epstein–Barr virus‐related hemophagocytic lymphohistiocytosis (EBV‐
HLH) in adults in the United States remain very limited. A cluster of four cases of EBV‐HLH …